As of 2025-03-21, the EV/EBITDA ratio of Willow Biosciences Inc (WLLW.TO) is -0.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WLLW.TO's latest enterprise value is 5.97 mil CAD. WLLW.TO's TTM EBITDA according to its financial statements is -6.28 mil CAD. Dividing these 2 quantities gives us the above WLLW.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-03-18 | -0.95 |
| 2025-03-17 | -0.95 |
| 2025-03-14 | -1.07 |
| 2025-03-13 | -1.07 |
| 2025-03-12 | -1.07 |
| 2025-03-11 | -0.95 |
| 2025-03-10 | -0.95 |
| 2025-03-07 | -0.95 |
| 2025-03-06 | -0.83 |
| 2025-03-05 | -0.83 |
| 2025-03-04 | -0.83 |
| 2025-03-03 | -0.83 |
| 2025-02-28 | -1.07 |
| 2025-02-27 | -0.95 |
| 2025-02-26 | -1.07 |
| 2025-02-25 | -1.07 |
| 2025-02-24 | -1.07 |
| 2025-02-21 | -1.07 |
| 2025-02-20 | -0.95 |
| 2025-02-19 | -1.07 |
| 2025-02-18 | -0.95 |
| 2025-02-14 | -0.72 |
| 2025-02-13 | -0.72 |
| 2025-02-12 | -0.72 |
| 2025-02-10 | -0.72 |
| 2025-02-07 | -0.83 |
| 2025-02-06 | -0.72 |
| 2025-02-05 | -0.72 |
| 2025-02-04 | -0.83 |
| 2025-02-03 | -0.72 |
| 2025-01-31 | -0.72 |
| 2025-01-30 | -0.72 |
| 2025-01-29 | -0.60 |
| 2025-01-28 | -0.72 |
| 2025-01-27 | -0.83 |
| 2025-01-24 | -0.83 |
| 2025-01-23 | -0.83 |
| 2025-01-22 | -0.83 |
| 2025-01-21 | -1.07 |
| 2025-01-20 | -1.07 |
| 2025-01-17 | -1.99 |
| 2025-01-16 | -1.87 |
| 2025-01-15 | -1.87 |
| 2025-01-14 | -1.76 |
| 2025-01-13 | -1.76 |
| 2025-01-10 | -1.76 |
| 2025-01-09 | -1.87 |
| 2025-01-08 | -1.87 |
| 2025-01-07 | -1.76 |
| 2025-01-06 | -1.87 |